KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Other Operating Expenses (2016 - 2025)

Bausch Health Companies' Other Operating Expenses history spans 17 years, with the latest figure at -$65.0 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 3150.0% year-over-year to -$65.0 million; the TTM value through Dec 2025 reached -$142.0 million, up 42.51%, while the annual FY2025 figure was -$142.0 million, 42.51% up from the prior year.
  • Other Operating Expenses for Q4 2025 was -$65.0 million at Bausch Health Companies, up from -$80.0 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $183.0 million in Q3 2021 and bottomed at -$542.0 million in Q2 2021.
  • The 5-year median for Other Operating Expenses is -$21.5 million (2023), against an average of -$45.8 million.
  • The largest YoY upside for Other Operating Expenses was 1243.75% in 2021 against a maximum downside of 4827.27% in 2021.
  • A 5-year view of Other Operating Expenses shows it stood at -$44.0 million in 2021, then skyrocketed by 34.09% to -$29.0 million in 2022, then rose by 3.45% to -$28.0 million in 2023, then skyrocketed by 92.86% to -$2.0 million in 2024, then tumbled by 3150.0% to -$65.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Other Operating Expenses are -$65.0 million (Q4 2025), -$80.0 million (Q3 2025), and $18.0 million (Q2 2025).